Revenue: The sum of all revenue fields included for a company's operating activities.
Innate Pharma SA (IPHYF) had Revenue of $21.77M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$21.77M |
$-53.53M |
|
-- |
|
$21.77M |
|
$77.58M |
|
$-55.81M |
|
$2.28M |
|
$-53.53M |
|
$-53.53M |
|
$-53.53M |
|
$-53.53M |
|
$-53.53M |
|
$-53.53M |
|
$-55.81M |
|
$-53.65M |
|
81.05M |
|
81.05M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$92.78M |
|
$5.55M |
|
$27.40M |
|
$120.18M |
|
$35.69M |
|
-- |
|
$74.93M |
|
$110.62M |
|
$9.56M |
|
$9.56M |
|
$9.56M |
|
83.84M |
|
| Cash Flow Statement Financials | |
$-7.46M |
|
$9.96M |
|
$-6.50M |
|
$76.40M |
|
$71.85M |
|
$-4.55M |
|
$4.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-256.32% |
|
-256.32% |
|
-246.41% |
|
-245.87% |
|
-245.87% |
|
$-7.89M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
4.05 |
|
90.19 |
|
-560.01% |
|
-560.01% |
|
-44.54% |
|
-560.01% |
|
$0.11 |
|
$-0.10 |
|
$-0.09 |
|